Aditxt (ADTX) Total Liabilities (2019 - 2026)
Aditxt (ADTX) recorded quarterly Total Liabilities of $49.1 million in Q1 2026, up 290.68% quarter-over-quarter from $12.6 million in Q4 2025, and up 217.51% on a YoY basis from $15.5 million in Q1 2025.
Aditxt (ADTX) Total Liabilities (2019 - 2026) Analysis & Trends
Aditxt's Total Liabilities history runs 8 years deep, the most recent figure standing at $49.1 million for Q1 2026.
- In Q1 2026, Total Liabilities rose 217.51% year-over-year to $49.1 million; the TTM figure through Mar 2026 stood at $49.1 million (up 217.51% YoY), while the FY2025 annual figure was $12.6 million, down 47.34% from the prior year.
- Total Liabilities was $49.1 million for Q1 2026 at Aditxt, up from $12.6 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $49.1 million in Q1 2026 to a low of $5.5 million in Q4 2022.
- Historically, Total Liabilities has averaged $17.4 million across 5 years, with a median of $15.5 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Total Liabilities surged 416.04% in 2023, then plunged 47.34% in 2025.
- A 5-year view of Total Liabilities shows it stood at $5.5 million in 2022, then soared by 416.04% to $28.5 million in 2023, then declined by 16.38% to $23.9 million in 2024, then slumped by 47.34% to $12.6 million in 2025, then soared by 290.68% to $49.1 million in 2026.
- The last three Total Liabilities figures came in at $49.1 million (Q1 2026), $12.6 million (Q4 2025), and $20.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | 49.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 49.08 Mn |
| Dec 31, 2025 | 12.56 Mn |
| Sep 30, 2025 | 20.66 Mn |
| Jun 30, 2025 | 20.70 Mn |
| Mar 31, 2025 | 15.46 Mn |
| Dec 31, 2024 | 23.86 Mn |
| Sep 30, 2024 | 25.39 Mn |
| Jun 30, 2024 | 22.03 Mn |
| Mar 31, 2024 | 18.19 Mn |
| Dec 31, 2023 | 28.53 Mn |
| Sep 30, 2023 | 12.45 Mn |
| Jun 30, 2023 | 11.16 Mn |
| Mar 31, 2023 | 7.57 Mn |
| Dec 31, 2022 | 5.53 Mn |
| Sep 30, 2022 | 6.49 Mn |
| Jun 30, 2022 | 9.38 Mn |
| Mar 31, 2022 | 7.07 Mn |
| Dec 31, 2021 | 6.48 Mn |
| Sep 30, 2021 | 6.61 Mn |
| Jun 30, 2021 | 9.94 Mn |